[Serotonin agonists and antagonists in migraine]

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Serotonin agonists and antagonists are primary treatments for acute and prophylactic migraine management, respectively.
• Current serotonin-based therapies exhibit incomplete efficacy and are associated with adverse effects.
• The use of these drugs supports a role for serotonin in migraine pathophysiology, implicating the trigeminal-vascular system.

Purpose of the Study:

• To review the role of serotonin in migraine pathophysiology.
• To evaluate the effectiveness and limitations of current serotonin-based migraine treatments.
• To explore potential additional mechanisms involved in migraine attacks.

Main Methods:

• Literature review of studies on serotonin agonists and antagonists in migraine treatment.
• Analysis of the pharmacological activity and proposed mechanisms of action.
• Synthesis of evidence supporting the involvement of the trigeminal-vascular system and other factors.

Main Results:

• Serotonin agonists and antagonists are widely utilized for acute and prophylactic migraine treatment.
• These treatments demonstrate incomplete effectiveness and are limited by side effects.
• Evidence supports serotonin's role in migraine, with the trigeminal-vascular system as a central component.

Conclusions:

• Serotonin plays a significant role in migraine pathophysiology.
• The trigeminal-vascular system is central to migraine attacks, though other mechanisms may contribute.
• Further research is needed to develop more effective and safer migraine therapies.